BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 10602430)

  • 1. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection.
    Dubovsky J; Daxberger H; Fritsch G; Printz D; Peters C; Matthes S; Gadner H; Lion T; Muller-Bérat N
    Leukemia; 1999 Dec; 13(12):2059, 2060-9. PubMed ID: 10602430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
    Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms.
    Suttorp M; Schmitz N; Dreger P; Schaub J; Löffler H
    Leukemia; 1993 May; 7(5):679-87. PubMed ID: 8097800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The kinetics of hematopoietic cell chimerism in the early period after non-myeloablative transplantation and its clinical implications].
    Xiao XB; Sun QY; Guo M; Qiao JH; Yu CL; Ai HS
    Zhonghua Xue Ye Xue Za Zhi; 2004 Aug; 25(8):466-9. PubMed ID: 15555261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of hematopoietic chimerism after allogeneic bone marrow transplantation by modern molecular techniques (STR-PCR and RQ-PCR)--single center].
    Czekalska S; Sacha T; Piatkowska-Jakubas B; Zawada M; Florek I; Cwynar D; Skotnicki AB
    Przegl Lek; 2010; 67(12):1282-91. PubMed ID: 21591354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing the method of chimerism monitoring after allogeneic stem cell transplantation using multiplex polymerase chain reaction amplification of short tandem repeat markers and Amelogenin.
    Sufliarska S; Minarik G; Horakova J; Bodova I; Bojtarova E; Czako B; Mistrik M; Drgona L; Demitrovicova M; Lakota J; Krivosikova M; Kovacs L
    Neoplasma; 2007; 54(5):424-30. PubMed ID: 17688372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children.
    Bader P; Hölle W; Klingebiel T; Handgretinger R; Benda N; Schlegel PG; Niethammer D; Beck J
    Bone Marrow Transplant; 1997 Apr; 19(7):697-702. PubMed ID: 9156247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of chimerism and early engraftment after allogeneic peripheral blood stem cell or bone marrow transplantation by short tandem repeats.
    Frankel W; Chan A; Corringham RE; Shepherd S; Rearden A; Wang-Rodriguez J
    Am J Hematol; 1996 Aug; 52(4):281-7. PubMed ID: 8701946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sequential and quantitative analysis of chimerism after non-myeloablative stem cell transplantation].
    Tang XW; Wu DP; Xia XM; Sun AN; Zhu ZL; Ruan CG
    Zhonghua Nei Ke Za Zhi; 2004 Feb; 43(2):98-101. PubMed ID: 15059404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative chimerism kinetics in relapsed leukemia patients after allogeneic hematopoietic stem cell transplantation.
    Qin XY; Li GX; Qin YZ; Wang Y; Wang FR; Liu DH; Xu LP; Chen H; Han W; Wang JZ; Zhang XH; Li JL; Li LD; Liu KY; Huang XJ
    Chin Med J (Engl); 2012 Jun; 125(11):1952-9. PubMed ID: 22884060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of mixed hematopoietic chimerism in pediatric patients with leukemia after allogeneic stem cell transplantation by quantitative PCR analysis of variable number of tandem repeat and testis determination gene.
    Wang LJ; Chou P; Gonzalez-Ryan L; Huang W; Haut PR; Kletzel M
    Bone Marrow Transplant; 2002 Jan; 29(1):51-6. PubMed ID: 11840144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transplant monitoring of chimerism by lineage-specific analysis.
    Preuner S; Lion T
    Methods Mol Biol; 2014; 1109():271-91. PubMed ID: 24473788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation.
    Breuer S; Preuner S; Fritsch G; Daxberger H; Koenig M; Poetschger U; Lawitschka A; Peters C; Mann G; Lion T; Matthes-Martin S
    Leukemia; 2012 Mar; 26(3):509-19. PubMed ID: 21926962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.
    Koldehoff M; Steckel NK; Hlinka M; Beelen DW; Elmaagacli AH
    Am J Hematol; 2006 Oct; 81(10):735-46. PubMed ID: 16838323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT.
    Bader P; Beck J; Frey A; Schlegel PG; Hebarth H; Handgretinger R; Einsele H; Niemeyer C; Benda N; Faul C; Kanz L; Niethammer D; Klingebiel T
    Bone Marrow Transplant; 1998 Mar; 21(5):487-95. PubMed ID: 9535041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation.
    Pérez-Simón JA; Caballero D; Diez-Campelo M; Lopez-Pérez R; Mateos G; Cañizo C; Vazquez L; Vidriales B; Mateos MV; Gonzalez M; San Miguel JF
    Leukemia; 2002 Aug; 16(8):1423-31. PubMed ID: 12145680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial quantification of lymphoid and myeloid mixed chimerism using multiplex PCR amplification of short tandem repeat-markers predicts graft rejection and relapse, respectively, after allogeneic transplantation of CD34+ selected cells from peripheral blood.
    Fernández-Avilés F; Urbano-Ispizua A; Aymerich M; Colomer D; Rovira M; Martínez C; Nadal E; Talarn C; Carreras E; Montserrat E
    Leukemia; 2003 Mar; 17(3):613-20. PubMed ID: 12646952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia.
    Barrios M; Jiménez-Velasco A; Román-Gómez J; Madrigal ME; Castillejo JA; Torres A; Heiniger A
    Haematologica; 2003 Jul; 88(7):801-10. PubMed ID: 12857560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
    Lawler M; McCann SR; Marsh JC; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socié G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A;
    Br J Haematol; 2009 Mar; 144(6):933-45. PubMed ID: 19183198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.